2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH

The present invention provides triazolone compounds of general formula (I):in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and...

Full description

Saved in:
Bibliographic Details
Main Authors Merz, Claudia, Sheikh, Sherif El, Kröber, Michael, Zimmermann, Katja, Müller, Thomas, Janzer, Andreas, Gradl, Stefan Nikolaus, Nguyen, Duy, Günther, Judith, Stellfeld, Timo, Sykes, David B, Christian, Sven, Niehues, Michael, Ferrara, Steven James, Nising, Carl Friedrich, Eis, Knut, Schäfer, Martina
Format Patent
LanguageEnglish
Published 28.09.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides triazolone compounds of general formula (I):in which R1, R2, R3, R4 and R5 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.
Bibliography:Application Number: US202016996721